Browsing by Author "Hevia, MD"

Now showing 1 - 1 of 1
  • No Thumbnail Available
    Item
    Two homozygous mutations in the 11β-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess
    (2003) Carvajal, CA; Gonzalez, AA; Romero, DG; González, A; Mosso, LM; Lagos, ET; Hevia, MD; Rosati, MP; Perez-Acle, TO; Gomez-Sanchez, CE; Montero, JA; Fardella, CE
    The human microsomal 11beta-hydroxysteroid dehydrogenase type 2 (11betaHSD2) metabolizes active cortisol into cortisone and protects the mineralocorticoid receptor from glucocorticoid occupancy. In a congenital deficiency of 11beta-HSD2, the protective mechanism fails and cortisol gains inappropriate access to mineralocorticoid receptor, resulting in low-renin hypertension and hypokalemia. In the present study, we describe the clinical and molecular genetic characterization of a patient with a new mutation in the HSD11B2 gene. This is a 4-yr-old male with arterial hypertension. The plasma renin activity and serum aldosterone were undetectable in the presence of a high cortisol to cortisone ratio. PCR amplification and sequence analysis of HSD11B2 gene showed the homozygous mutation in exon 4 Asp223Asn (GAC --> AAC) and a single nucleotide substitution C-->T in intron 3. Using site-directed mutagenesis, we generated a mutant 11betaHSD2 cDNA containing the Asp223Asn mutation. Wild-type and mutant cDNA was transfected into Chinese hamster ovary cells and enzymatic activities were measured using radiolabeled cortisol and thin-layer chromatography. The mRNA and 11betaHSD2 protein were detected by RT-PCR and Western blot, respectively. Wild-type and mutant 11betaHSD2 protein was expressed in Chinese hamster ovary cells, but the mutant enzyme had only 6% of wildtype activity. In silico 3D modeling showed that Asp223Asn changed the enzyme's surface electrostatic potential affecting the cofactor and substrate enzyme-binding capacity. The single substitution C-->T in intron 3 (IVS3 + 14 C-->T) have been previously reported that alters the normal splicing of pre-mRNA, given a nonfunctional protein. These findings may determine the full inactivation of this enzyme, explaining the biochemical profile and the early onset of hypertension seen in this patient.